Exclusive Speaker Interview with Karen Capper, AstraZeneca ahead of the Pharmaceutical Microbiology

SMi Group reports: exclusive speaker interview with microbiology expert Karen Capper, AstraZeneca about the developments in the microbiology field.
By: SMi Group
 
LONDON - Jan. 7, 2022 - PRLog -- Now in its 10th Annual year, the Pharmaceutical Microbiology UK conference is one not to be missed. Taking place on 17th and 18th January 2022 as a virtual conference with online access only.

The conference will bring together industry experts to discuss and analyse the latest advancements and challenges within pharmaceutical microbiology.

Interested parties can register for the conference and the two interactive workshops at http://www.pharma-microbiology.com/PNHQPR5 (http://www.pharma-microbiology.com/PR5)

Ahead of the virtual conference taking place in less than two weeks, SMi Group caught up with Karen Capper, Associate Director - Head of Microbiology, Pharmaceutical Development, AstraZeneca. Below is the excerpts of the interview:

The industry surrounding pharmaceutical microbiology is maturing each year, in your opinion, what are some of the most major developments that have taken place in the last year?
The need to act quickly through the pandemic has enabled more acceptance of rapid methods and new technology in microbiology.  The microbiologists need to ensure this momentum is maintained and the industry continues to use some of this technology for pharmaceutical products.

What are your thoughts on the shifting regulatory environment, and how is this currently impacting your role?
The main impacts I see in the regulatory environment is managing the various market requirements whilst running an efficient business.  The need to comply with more rest of the world markets has led to complexity in method development and acceptance.

To read the full interview visit the download centre on the conference website to read the full interview at http://www.pharma-microbiology.com/PNHQPR5 (http://www.pharma-microbiology.com/PR5)

Karen Capper will be presenting on day two of the Pharmaceutical Microbiology UK Virtual Conference along with Suzanne Nutter, QA Group Manager, AstraZeneca on: "Applying Virtual Reality To Training In Aseptic Processing & Microbiology" which will cover:
  • Overview of the technology
  • Rollout plan and approach
  • Pros and cons of the technology for training

The conference is proudly sponsored by ECOLAB and Microgenetics

For media enquiries and press pass requests, contact Simi Sapal, Head of Marketing on +44 (0) 20 7827 6162 or ssapal@smi-online.co.uk

SMi's 10th Annual Pharmaceutical Microbiology Conference

Conference: 17 - 18 January 2022

Workshops: 19 January 2022

Virtual Conference: Online Access Only

http://www.pharma-microbiology.com/PNHQPR5

#SMiPharmaMicroUK

Contact
SMi Group
Simi Sapal
***@smi-online.co.uk
End
Email:***@smi-online.co.uk Email Verified
Tags:Pharmaceutical Microbiology
Industry:Medical
Location:London City - London, Greater - England
Subject:Events
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd. News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share